SEC 13F Intelligence

Brookmont Capital Management / GILD

Brookmont Capital Management’s Gilead Sciences Inc Position

Does Brookmont Capital Management own Gilead Sciences Inc (GILD)? Yes — 37.7K shares worth $5M (+2.94% of its 13F portfolio) as of Q1 2026, up from 36.6K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
37.7K
% of Portfolio
+2.94%
Quarters Held
30
currently held

Position History GILD

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $3MQ3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $3MQ2 ’20: $2MQ3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ3 ’21: $2MQ4 ’21: $2MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ3 ’22: $2MQ4 ’22: $4MQ4 ’22Q1 ’23: $4MQ2 ’23: $4MQ3 ’23: $3MQ4 ’23: $4MQ4 ’23Q1 ’24: $3MQ2 ’24: $3MQ3 ’24: $4MQ4 ’24: $5MQ4 ’24Q1 ’25: $4MQ2 ’25: $4MQ3 ’25: $4MQ4 ’25: $4MQ4 ’25Q1 ’26: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202637.7K$5M+2.94%
Q4 202536.6K$4M+2.60%
Q3 202536.6K$4M+2.26%
Q2 202537.6K$4M+2.39%
Q1 202538.5K$4M+2.43%
Q4 202451.1K$5M+2.52%
Q3 202443.8K$4M+1.89%
Q2 202445.2K$3M+1.70%
Q1 202446.7K$3M+1.80%
Q4 202345.7K$4M+2.07%
Q3 202346.5K$3M+2.17%
Q2 202346.8K$4M+2.18%
Q1 202346.8K$4M+2.44%
Q4 202246.6K$4M+2.46%
Q3 202229.3K$2M+1.26%
Q2 202227.0K$2M+1.15%
Q1 202226.6K$2M+0.95%
Q4 202126.1K$2M+1.00%
Q3 202127.2K$2M+1.12%
Q2 202126.7K$2M+1.11%
Q1 202126.6K$2M+1.11%
Q4 202026.5K$2M+1.09%
Q3 202028.1K$2M+1.32%
Q2 202027.6K$2M+1.70%
Q1 202038.8K$3M+2.34%
Q4 201935.6K$2M+1.38%
Q3 201938.5K$2M+1.39%
Q2 201938.6K$3M+1.57%
Q1 201938.4K$2M+1.54%
Q4 201838.3K$2M+1.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Brookmont Capital Management’s full portfolio or all institutional holders of GILD.